Clinical Trials Directory

Trials / Completed

CompletedNCT01734330

Cognitive Behaviour Therapy and Nicotine Replacement to Increase Tobacco Cessation

Efficacy of Cognitive Behaviour Therapy Associated to Nicotine Replacement in Tobacco Cessation: a Randomised Open Label Clinical Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
200 (actual)
Sponsor
Hospital do Coracao · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

Background: Pharmacological strategies to improve smoking cessation have been largely studied. The efficacy of cognitive behavior therapy associated to nicotine replacement in tobacco cessation has not yet been demonstrated. Objective: Evaluate if cognitive behavior therapy during six weeks associated to nicotine replacement for twelve weeks is able to contribute to tobacco cessation at the end of 52 weeks. Methods: Multicentre, open-label, and pragmatic randomized controlled trial will include 334 patients. Analysis will follow intention-to-treat principle. Patients older than 18 years old and who had smoked at least 5 cigarettes in the past year before randomization will be included. All of them will receive nicotine replacement therapy with patches and gum. They will be randomized 1:1 ratio to attend or not cognitive behavior therapy once a week for the first six weeks of the treatment. Every two weeks all of the patients will be evaluated by a physician in order to access any adverse effects from the nicotine replacement. All patients will have carbon monoxide levels accessed at baseline and after 6 weeks. Telephonic interview will be done at 16, 28, and 52 weeks to access the rates of tobacco cessation, relapses episodes and abstinence maintenance.

Conditions

Interventions

TypeNameDescription
BEHAVIORALCognitive behavioral therapy in group
DRUGNicotine replacement

Timeline

Start date
2010-07-01
Primary completion
2012-09-01
Completion
2012-11-01
First posted
2012-11-27
Last updated
2012-11-27

Locations

2 sites across 1 country: Brazil

Source: ClinicalTrials.gov record NCT01734330. Inclusion in this directory is not an endorsement.